One of Taiwan's top three chain pharmacies, Norbel, announced on the evening of June 18 that its board of directors has undergone a complete reorganization. The new chairman will be Yang Hongpei, Vice Chairman of BenQ Group and BenQ Medical Equipment.
During the shareholders' meeting on June 18, several resolutions were passed, and supervisors were elected. The new board consists of six directors and three independent directors. The directors include Chen- Hsing Chang, Wang-Shen Hsu, Hung-Pei Yang (representative of Qisda), Yao-Hung Hsu, Sheng-Lung Shen (representative of Qisda), and Hua-Tsung Wu. The independent directors are Pao-Lin Huang, Chi-Kuo Tseng, and Pao-Che Huang.
Following the shareholders' meeting, the new board convened and elected Hung-Pei Yang as the new chairman of Norbel. Hung-Pei Yang also currently serves as the co-general manager of Qisda's medical division.
Qisda announced on April 21 last year that to strengthen its position in the medical retail market and capitalize on opportunities in the aging population sector, its board had decided to subscribe to Norbel's private placement of common stock and conduct a public tender offer. The total investment amounted to NT$1.8 billion, securing a 28.54% stake. Qisda stated that this investment would allow for complementary resource sharing and joint expansion of the medical retail market.
In March this year, when Norbel was listed on the over-the-counter market, it declared plans to expand its elder care market through its Ding Ding Pharmacy chain. The company aims to grow from 92 stores to over 100 by the end of this year through franchising and acquisitions.
Resource (mandarin):
